Biodep Biotechnology is a biotechnology company founded in 2017 that focuses on research, solutions, and applications in various fields including foodstuff, cosmetics, healthy food, animal health, environmental treatment, modern agriculture, and more. Their main products include high-activity probiotics powder, capsules, and tablets. The company prides itself on being a pioneer in the probiotics industry in China and sets its value as "Bio-Tech Shapes Our Future," emphasizing the role of biotechnology as the driving force for development and the creation of a healthy lifestyle.
The latest venture round investment in the company was on 11 January 2024, with participation from GF Xinde, Fu Yuan Investment, and CMB International Capital Corporation. This investment reflects the confidence of these investors in Biodep Biotechnology's potential for growth and impact in the health care industry. The company's expertise in biotech productions and functional food formulations positions it as an attractive opportunity for venture capital funding.
